47 results
Page 2 of 3
8-K
EX-99.1
jff4vzr0oibv 8a
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.2
6zz mknxnp9bgy6pyq6
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
rrkn e1mi0s0m5gj7a
25 May 23
Regulation FD Disclosure
5:05pm
8-K
4f7pon7wsp2xsg711
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
tni3 51vd
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
S-3
aercfqs g8
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
085kdpxzt5be
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
alpb1ba8b
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
hpefe2fganezodk5h
9 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
EX-99.1
eycg93mes2jtw6x7udbz
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
8-K
EX-99.2
vk9b441
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
trxush
26 Apr 22
Definitive proxy
4:05pm
10-K
7m4a yf8iqa68eu
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
0gwpj168is
1 Mar 22
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
EX-99.1
83tntbqj 3tovst
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am